GlycoMimetics Statistics
Total Valuation
GlycoMimetics has a market cap or net worth of $26.44 million. The enterprise value is $4.50 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GlycoMimetics has 64.48 million shares outstanding. The number of shares has increased by 12.03% in one year.
Current Share Class | 64.48M |
Shares Outstanding | 64.48M |
Shares Change (YoY) | +12.03% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 8.35% |
Owned by Institutions (%) | 12.12% |
Float | 44.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.32 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 450.11 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.02.
Current Ratio | 5.48 |
Quick Ratio | 5.16 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -104.49% and return on invested capital (ROIC) is -66.72%.
Return on Equity (ROE) | -104.49% |
Return on Assets (ROA) | -59.25% |
Return on Capital (ROIC) | -66.72% |
Revenue Per Employee | $286 |
Profits Per Employee | -$1.12M |
Employee Count | 35 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.63% in the last 52 weeks. The beta is 1.84, so GlycoMimetics's price volatility has been higher than the market average.
Beta (5Y) | 1.84 |
52-Week Price Change | -69.63% |
50-Day Moving Average | 0.19 |
200-Day Moving Average | 1.14 |
Relative Strength Index (RSI) | 72.13 |
Average Volume (20 Days) | 60,302,220 |
Short Selling Information
The latest short interest is 1.83 million, so 2.83% of the outstanding shares have been sold short.
Short Interest | 1.83M |
Short Previous Month | 1.64M |
Short % of Shares Out | 2.83% |
Short % of Float | 4.13% |
Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, GlycoMimetics had revenue of $10,000 and -$39.11 million in losses. Loss per share was -$0.61.
Revenue | 10,000 |
Gross Profit | 10,000 |
Operating Income | -40.88M |
Pretax Income | -39.11M |
Net Income | -39.11M |
EBITDA | -40.78M |
EBIT | -40.88M |
Loss Per Share | -$0.61 |
Full Income Statement Balance Sheet
The company has $22.39 million in cash and $448,775 in debt, giving a net cash position of $21.94 million or $0.34 per share.
Cash & Cash Equivalents | 22.39M |
Total Debt | 448,775 |
Net Cash | 21.94M |
Net Cash Per Share | $0.34 |
Equity (Book Value) | 20.06M |
Book Value Per Share | 0.31 |
Working Capital | 19.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$35.70 million and capital expenditures -$18,639, giving a free cash flow of -$35.72 million.
Operating Cash Flow | -35.70M |
Capital Expenditures | -18,639 |
Free Cash Flow | -35.72M |
FCF Per Share | -$0.55 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -408,770.51% |
Pretax Margin | -391,132.31% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -357,190.33% |
Dividends & Yields
GlycoMimetics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.03% |
Shareholder Yield | -12.03% |
Earnings Yield | -147.94% |
FCF Yield | -135.10% |
Analyst Forecast
The average price target for GlycoMimetics is $12.00, which is 2,826.83% higher than the current price. The consensus rating is "Hold".
Price Target | $12.00 |
Price Target Difference | 2,826.83% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 404.16% |
EPS Growth Forecast (5Y) | -24.51% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GlycoMimetics has an Altman Z-Score of -16.15 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.15 |
Piotroski F-Score | 1 |